Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
about
The Role of Mass Spectrometry in the "Omics" EraTwo classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS.Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data.Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.The application of SELDI-TOF-MS in clinical diagnosis of cancersCollagen-based proteinaceous binder-pigment interaction study under UV ageing conditions by MALDI-TOF-MS and principal component analysis.Before you analyze a human specimen, think quality, variability, and bias.An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis.Capillary-channeled polymer (C-CP) fibers for the rapid extraction of proteins from urine matrices prior to detection with MALDI-MS.Reproducibility in urine peptidome profiling using MALDI-TOF.State-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics.Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations.Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?Enhancing translational research in paediatric rheumatology through standardization.Analysis of aquatic-phase natural organic matter by optimized LDI-MS method.
P2860
Q28660980-A28D257E-F5D3-4596-97A1-DD1D8A7DBA10Q30456214-3504267F-9F07-4679-8210-BC4FFFA786D9Q31139690-7C8A13E4-51F0-4B77-BA55-DB75C34CA1B5Q31148183-59E9C49E-5591-451C-8E12-54F9AD9CCFDEQ33936575-E1E11912-D363-49B2-8BC6-499446110896Q34202574-74A57CAE-D254-427C-8146-468F34CC5C04Q34462735-1C480E04-DC92-4C7A-933D-0CCE77684AC6Q35423674-27903A12-942B-4BBA-A8C1-E0FFB70D44B6Q35467651-84F5C577-6729-4D2C-905E-289E3BDE0B7EQ35530393-9EB08142-6CE4-419C-96A0-2335A79A708CQ35570959-28C6C0EA-FDB6-4B20-817E-15AF0F2893FBQ35880037-3571EFF6-2D5B-4038-BA36-8DAAB3E459DEQ38190894-5C94A2F1-02D4-4A52-9073-31BC6C29AF70Q38960512-B41867E7-0822-42AA-8F10-11621EAECA27Q53632453-4C4FA528-2358-41E9-9736-C07C54132E51
P2860
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Optimization of analytical and ...... human urine protein profiles.
@ast
Optimization of analytical and ...... human urine protein profiles.
@en
type
label
Optimization of analytical and ...... human urine protein profiles.
@ast
Optimization of analytical and ...... human urine protein profiles.
@en
prefLabel
Optimization of analytical and ...... human urine protein profiles.
@ast
Optimization of analytical and ...... human urine protein profiles.
@en
P2093
P1476
Optimization of analytical and ...... human urine protein profiles.
@en
P2093
C Bettocchi
C D Calvano
C G Zambonin
G E De Benedetto
M Battaglia
M Iacovone
M Rutigliano
P304
P356
10.1016/J.JPBA.2009.10.014
P577
2009-10-30T00:00:00Z